ZAP, US. Zomig for Appropriate for Primary Care

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
The purpose of this study is to determine how useful and effective the use of ZOMIG-ZMT™ (zolmitriptan) 5.0 mg and ZOMIG® Nasal Spray (zolmitriptan) 5.0 mg is for patients, in treating migraine over a period of 6 months
Epistemonikos ID: 9a0aef23c257a2fc28718d60dd8e1fda44f5a52d
First added on: May 04, 2024